Annexon biosciences to participate in the 6th annual evercore isi healthconx conference

Brisbane, calif., nov. 22, 2023 (globe newswire) -- annexon, inc. (nasdaq: annx), a clinical-stage biopharmaceutical company developing a new class of complement-based medicines for people living with devastating inflammatory-related diseases, today announced that douglas love, president and chief executive officer, will participate in a fireside chat during the 6th annual evercore isi healthconx conference on wednesday, november 29, 2023 at 2:10 p.m. et in miami.
ANNX Ratings Summary
ANNX Quant Ranking